Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide and WBRT in NSCLC Brain Metastases
NCT02385136Phase 2Unknown
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Apr 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of temozolomide in brain metastases, sponsored by Zhejiang Cancer Hospital. Status: unknown.
02
Drugs
temozolomide
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT02385136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02385136.